Logo

Paired Ends: Mark Stevenson, Greg Lucier

Feb 04, 2014
Premium

As part of Thermo Fisher Scientific's acquisition of Life Technologies, Thermo has established a new business segment called Life Sciences Solutions. Mark Stevenson will serve as executive vice president and president of Life Sciences Solutions, reporting to Thermo Fisher CEO Marc Casper. Stevenson was previously COO of Life Technologies.

Greg Lucier, former CEO of Life Technologies, is not joining the new company. Last fall, he was named chairman of Sanford-Burnham Medical Research Institute. Lucier said he will also be investing in start-ups and mentoring CEOs.

Filed under

Clinical Sequencing
Sequencing
Next-Generation Sequencing
Thermo Fisher Scientific
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.